[email protected] +254 731 337179 Quality Products. Healthy Animals. Prosperous Farms.

Company Overview

Kenvet Afri Limited

Kenvet Afri Limited is an emerging veterinary pharmaceutical enterprise headquartered in Nairobi, Kenya, with operational footprints across East Africa and China.

Company Overview

Kenvet Afri Limited is dedicated to the research, development, and supply of high-quality veterinary medicines, feed additives, and animal health solutions for livestock, poultry, companion animals, and aquaculture.

Leveraging a strategic Contract Manufacturing Organization (CMO) model, Kenvet Afri Limited collaborates with globally recognized manufacturing partners in China, while maintaining a strong local presence in Kenya to ensure regulatory compliance, supply chain reliability, and market accessibility across Africa.

Livestock Poultry Companion Animals Aquaculture
Veterinary team caring for cattle on a rural farm
East Africa and China Local market access supported by international manufacturing partnerships.

Strategic CMO Partnership

Trusted manufacturing partnerships in China.

Through its CMO model, Kenvet Afri Limited engages multiple GMP-certified veterinary pharmaceutical manufacturers in China for the production of its product portfolio.

Operations in Kenya

A local hub for distribution and regulatory affairs.

In Kenya, Kenvet Afri Limited operates a distribution and regulatory affairs hub to serve the East African veterinary market.

China CMO Coverage

Comprehensive veterinary pharmaceutical support

Active Pharmaceutical Ingredients

Sourcing of high-potency veterinary APIs including florfenicol, tilmicosin, enrofloxacin, toltrazuril, oxytetracycline, penicillins, doxycycline, and dexamethasone from facilities equipped with 14+ API production lines.

Finished Dosage Forms

Contract manufacturing of injectables, oral solutions, soluble powders, tablets, granules, and premixes.

Comprehensive CMO Services

Full-spectrum support including formulation development, analytical method development, stability studies, technology transfer, scale-up, commercial manufacturing, and process improvement.

Regulatory and Logistics Support

Assistance with China market registration, customs clearance, warehousing, and international logistics for export to Africa.

Quality Commitment

Aligned with local and international standards

All CMO partners are certified under China's GMP standards, with some holding additional international accreditations such as Australia APVMA and Philippines GMP, ensuring that products meet both Chinese regulatory requirements and the import standards of Kenya and other African markets.

Kenya GMP requirements for veterinary manufacturing and import
ISO/IEC 17025:2017, VICH, and ICH guidelines
Good Distribution Practices for supply chain integrity
Stability testing and quality control checks before market release

Kenya Activities

Registered local operations for East Africa

The company is registered with the Kenya Veterinary Board (KVB) and the Veterinary Medicines Directorate (VMD), complying with local requirements for import, warehousing, and distribution of veterinary medicines under the Veterinary Medicines Directorate Regulations, 2015.

Product Registration

Registration for veterinary medicines, including products researched locally and outside Kenya.

Warehousing

Warehousing and cold-chain management for biologics and sensitive formulations.

Technical Support

Local sales, technical support, and veterinary training programs for farmers and animal health professionals.

Product Portfolio

Focused animal health segments

Livestock Pharmaceuticals: antibiotics, antiparasitics, anti-inflammatories, and hormonal products for cattle, sheep, goats, and pigs.
Poultry Health: vaccines, anti-coccidials, and nutritional supplements.
Companion Animal Care: pet-specific medicines, dermatological products, and nutraceuticals.
Feed Additives and Premixes: medicated and non-medicated premixes to support productivity and disease prevention.

Market & Growth Potential

Promising opportunities in Kenya's animal health market

The animal health market in Kenya presents promising investment opportunities, driven by increasing demand for veterinary products and services from a growing livestock industry. With Kenya's livestock sector contributing approximately 12% to national GDP, and national vaccine production targets doubling to 70 million doses by 2027, the market offers significant runway for growth.

12% Livestock contribution to national GDP 70M Vaccine dose target by 2027